ATE490981T1 - Criptospezifische antikörper - Google Patents

Criptospezifische antikörper

Info

Publication number
ATE490981T1
ATE490981T1 AT02807155T AT02807155T ATE490981T1 AT E490981 T1 ATE490981 T1 AT E490981T1 AT 02807155 T AT02807155 T AT 02807155T AT 02807155 T AT02807155 T AT 02807155T AT E490981 T1 ATE490981 T1 AT E490981T1
Authority
AT
Austria
Prior art keywords
cripto
antibodies
inhibit
bind
specific antibodies
Prior art date
Application number
AT02807155T
Other languages
English (en)
Inventor
Michele Sanicola-Nadel
Huet Heather Adkins
Steven Donald Miklasz
Paul Rayhorn
Susan Gail Schiffer
Kevin Williams
Original Assignee
Biogen Idec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/011950 external-priority patent/WO2002088170A2/en
Application filed by Biogen Idec Inc filed Critical Biogen Idec Inc
Priority claimed from PCT/US2002/031462 external-priority patent/WO2003083041A2/en
Application granted granted Critical
Publication of ATE490981T1 publication Critical patent/ATE490981T1/de

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT02807155T 2002-03-22 2002-10-01 Criptospezifische antikörper ATE490981T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36700202P 2002-03-22 2002-03-22
PCT/US2002/011950 WO2002088170A2 (en) 2001-04-26 2002-04-17 Cripto blocking antibodies and uses thereof
PCT/US2002/031462 WO2003083041A2 (en) 2002-03-22 2002-10-01 Cripto-specific antibodies

Publications (1)

Publication Number Publication Date
ATE490981T1 true ATE490981T1 (de) 2010-12-15

Family

ID=34061765

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02807155T ATE490981T1 (de) 2002-03-22 2002-10-01 Criptospezifische antikörper

Country Status (9)

Country Link
JP (1) JP2009161539A (de)
AT (1) ATE490981T1 (de)
CA (1) CA2480119C (de)
CY (1) CY1111320T1 (de)
DE (1) DE60238559D1 (de)
DK (1) DK1494693T3 (de)
ES (1) ES2355363T3 (de)
HK (1) HK1072381A1 (de)
PT (1) PT1494693E (de)

Also Published As

Publication number Publication date
ES2355363T3 (es) 2011-03-25
PT1494693E (pt) 2011-02-23
JP2009161539A (ja) 2009-07-23
DK1494693T3 (da) 2011-01-17
CA2480119A1 (en) 2003-10-09
DE60238559D1 (de) 2011-01-20
CA2480119C (en) 2014-04-08
CY1111320T1 (el) 2015-08-05
HK1072381A1 (en) 2005-08-26

Similar Documents

Publication Publication Date Title
WO2003083041A3 (en) Cripto-specific antibodies
MY150237A (en) Cripto blocking antibodies and uses thereof
BR0011838A (pt) Elementos misturadores estáticos empilhados
CY1111622T1 (el) Ανθρωποποιημενοι ανταγωνιστες anti-cmet
PL1615952T3 (pl) Sposoby leczenia chorób zapalnych z zastosowaniem środków specyficznie wiążących ludzką angiopoetynę-2
NO20041917L (no) Spesifikke midler som binder humant angiopoietin-2
EP1784639A4 (de) Verfahren zur herstellung gefriergetrockneter blutplättchen, gefriergetrocknete blutplättchen enthaltende zusammensetzungen und verwendungsverfahren
TNSN05300A1 (en) Treatment with anti-vegf antibodies
AU2003205077A1 (en) Imaging agents and methods of imaging naaladase of psma
EA200602047A1 (ru) Сульфонилэтилфосфородиамидаты, предназначенные для применения при лечении рака
IL163902A0 (en) Antibodies against cancer antigen tmeff2 and uses thereof
ATE490981T1 (de) Criptospezifische antikörper
DE50210279D1 (de) Screeningverfahren mit bnpi und dnpi
TW200635951A (en) Specific binding agents of human angiopoietin-2

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1494693

Country of ref document: EP